Aromasin en es it fr

Categoria

Aromasin Marchi, Aromasin Analoghi

Aromasin Marchi miscela

  • No information avaliable
  • Aromasin Formula chimica

    C20H24O2

    Aromasin RX link

    http://www.rxlist.com/cgi/generic3/exemest.htm

    Aromasin FDA foglio

    Aromasin FDA

    Aromasin DMS (foglio di materiale di sicurezza)

    Aromasin Sintesi di riferimento

    Pfizer Canada Inc, numero di brevetto: 1277656

    Aromasin Peso molecolare

    296.403 g/mol

    Aromasin Temperatura di fusione

    155.13oC

    Aromasin H2O Solubilita

    Non solubili

    Aromasin Stato

    Solid

    Aromasin LogP

    4.222

    Aromasin Forme di dosaggio

    Compressa

    Aromasin Indicazione

    Per il trattamento del carcinoma mammario avanzato nelle donne in post-menopausa la cui malattia è progredita dopo terapia con tamoxifene.

    Aromasin Farmacologia

    Aromatasi è un enzima che converte gli ormoni in estrogeni nelle ghiandole surrenali del corpo. Gli inibitori dell'aromatasi (AI) sono farmaci che riducono i livelli di estrogeni bloccando l'azione dell'aromatasi nel surrene ghiandole. L'AIS selettivo (ISC) selettivamente ridurre i livelli di estrogeni senza interferire con i livelli di altri ormoni steroidei che sono prodotte dalla ghiandola surrenale. Farmaci di questa classe includono anastrozolo (Arimidex ™), Letrozolo (Femara ™) ed Exemestane (Aromasin ™).

    Aromasin Assorbimento

    42%

    Aromasin Tossicita

    Convulsioni

    Aromasin Informazioni paziente

    PATIENT INFORMATION

    If clinically advisable, patients receiving OxyContin (oxycodone hydrochloride controlled-release) tablets or
    their caregivers should be given the following information by the physician, nurse, pharmacist, or caregiver:

    1. Patients should be aware that OxyContin tablets contain oxycodone, which is a morphine-like substance.

    2. Patients should be advised that OxyContin tablets were designed to work properly only if swallowed whole.
    OxyContin tablets will release all their contents at once if broken, chewed, or crushed, resulting in a risk of
    fatal overdose.

    3. Patients should be advised to report episodes of breakthrough pain and adverse experiences occurring during
    therapy. Individualization of dosage is essential to make optimal use of this medication.

    4. Patients should be advised not to adjust the dose of OxyContin without consulting the prescribing professional.

    5. Patients should be advised that OxyContin may impair mental and/or physical ability required for the performance
    of potentially hazardous tasks (e.g., driving, operating heavy machinery).

    6. Patients should not combine OxyContin with alcohol or other central nervous system depressants (sleep aids,
    tranquilizers) except by the orders of the prescribing physician, because dangerous additive effects may occur,
    resulting in serious injury or death.

    7. Women of childbearing potential who become, or are planning to become, pregnant should be advised to consult their
    physician regarding the effects of analgesics and other drug use during pregnancy on themselves and their unborn child.

    8. Patients should be advised that OxyContin is a potential drug of abuse. They should protect it from theft, and it
    should never be given to anyone other than the individual for whom it was prescribed.

    9. Patients should be advised that they may pass empty matrix "ghosts" (tablets) via colostomy or in the stool, and that
    this is of no concern since the active medication has already been absorbed.

    10. Patients should be advised that if they have been receiving treatment with OxyContin for more than a few weeks and
    cessation of therapy is indicated, it may be appropriate to taper the OxyContin dose, rather than abruptly discontinue
    it, due to the risk of precipitating withdrawal symptoms. Their physician can provide a dose schedule to accomplish a
    gradual discontinuation of the medication.

    11. Patients should be instructed to keep OxyContin in a secure place out of the reach of children. When OxyContin is
    no longer needed, the unused tablets should be destroyed by flushing down the toilet.

    Aromasin Atto interessato organismi

    Gli esseri umani e altri mammiferi